A multi-center study found that 63% of patients with mild to moderate ulcerative colitis achieved remission after taking four packets of VSL#3 daily for six weeks. The probiotic composition demonstrated safety and efficacy in patients not responding to conventional therapies.
A randomised controlled trial found that patient-centred self-management training reduced relapse times and hospital visits, while maintaining health-related quality-of-life scores. This alternative approach to traditional outpatient care may improve health-service provision and reduce costs for chronic diseases.
A UK-based study of over 17,000 people found left handers more than twice as likely to be affected by Crohn's disease and ulcerative colitis. The research suggests later birth may play a role in the increased risk, but the exact cause remains unknown.